About BCRO

Brief Introduction of BCRO

BCRO is the sole leader of the fetal precursor cell xeno-transplantation field as cell transplantation has been our business for more than 33 years now: we researched it, and developed it commercially from the ground. BCRO has brought this old traditional therapy up to the ‘state-of-art’ level, in particular by developing the preparation of cell xeno-transplants, with worldwide delivery.

Bio-Cellullar Research Organization (‘BCRO’) was founded in 1989, as a U.K. company (England and Wales). In January 1992 a company of the same name was registered in Ireland, and the U.K. company was closed down.

In 2001, when a new U.S. administration of President Bush began to support Stem Cell Transplantation, the company of the same name was registered in U.S., and the Irish company was closed down. It has always been a limited liability company.

In 2009 the company returned to Ireland, registered under the name Stem Cell Transplantation Ltd. (and the business name ‘Bio-Cellular Research Organization’).

From 1976 until 1989 this project was carried out under various California corporations and non-profit foundations.

Our mission

  1. Manufacture the ‘state-of-art’ BCRO fetal precursor cell xeno-transplants by primary tissue culture in accordance with our proprietary procedure and related know-how, to be used for treatment that has saved lives and minimized the disability of patients, particularly those declared beyond help by modern medicine,
  2. Deliver our BCRO cell transplants worldwide,
  3. Educate and consult physicians and patients in the clinical aspects of cell transplantation.

Biography of Dr. E. Michael Molnar

Prof. MUDr. E. Michael Molnar, M.D., M.S., graduated in June 1965 summa cum laude, 4.0. grade average, from the Faculty of Medicine, Komensky University, Bratislava, Czechoslovakia. Following the invasion of Warsaw Pact armies into Czechoslovakia on August 21, 1968, he emigrated to the United States at the age of 26, already certified by the Czechoslovak Board of Head and Neck Surgery, and appointed a County Consultant for Pediatric Head & Neck Surgery.

Dr. Molnar repeated his residency training (1971-75) as required by US authorities. During this period he was an Assistant at A. Lincoln School of Medicine in Chicago, Ill., and a graduate student at the University of Illinois Medical Center, Chicago, Ill. In 1975 he was certified by the American Board of Head and Neck Surgery and received a Master of Science degree in physiology from the University of Illinois at the Medical Center in Chicago, Ill.

After 1975, Dr. Molnar developed a private practice of head & neck, and plastic & reconstructive surgery in Los Angeles. He was a Clinical Professor at C. Drew Medical School in Los Angeles, Calif. The news of horrible death of his father from complications of diabetes mellitus in 1976 caused Dr. Molnar to search for treatments for incurable and no longer treatable diseases. This research culminated in a public educational campaign on TV about such therapies. He published in 1984 in the U.S. the first book for general public about aging disease written by U.S. physician.

Unexpectedly, for a physician from Europe, such activities brought on severe attacks by the U.S. medical industry and Dr. Molnar decided to return to Europe in 1988 to pursue his research on fetal precursor cell transplantation. In 1988, he obtained the approval of the Yugoslav authorities to start a clinical research project at medical schools in Sarajevo and Zagreb which had to be stopped in 1990 due to the onset of the civil war. So Dr. Molnar approached Prof. Dr. Chazov, U.S.S.R. Minister of Health, Nobel Peace Prize winner, with a request to continue his work in the Soviet Union. Dr. Molnar was invited by him to Moscow in June 1990 to launch a very successful project on the use of fetal presursor cell transplantation as a treatment for a wide variety of incurable and no longer treatable diseases in cooperation with the 20 top Russian medical research institutes under the title ‘International Institute of Biological Medicine’..

Dr. Molnar is one of the few physicians with extensive experience in both animal and human fetal precursor cell transplantation, and qualified to warn against the dangers of human embryonic stem cell transplantation. Dr. Molnar explains in his textbook for physicians ‘Stem Cell Transplantation, a Textbook of Stem Cell Xeno-Transplantation, published in 2006 in U.S. his preference for fetal precursor cell xeno-transplantation (animal fetal) over allo-transplantation (human fetal). Directly, or under Dr. Molnar’s supervision, 15,000 patients have been treated by various techniques of fetal precursor cell transplantation in the U.S.S.R./Russia, U.S.A., Germany, Italy, Switzerland, Czechoslovakia, Yugoslavia, Mexico, Malaysia, Thailand, Indonesia, Qatar, South Africa, Nigeria, Panama, Austria, Australia, India, Peoples’ Republic of China, Hong Kong, Macau. Besides these countries he lectured repeatedly on cell transplantation in Turkey, Taiwan, South Korea, Cambodia, Kuwait, Egypt, Jordan, Dubai, Rumania, Republic of Georgia, and visited with the Ministers of Health about cell transplantation in many other countries.

In September 1996, the U.S. FDA issued a draft of guidelines on the use of cell & tissue xeno-transplantation that made possible an official cooperation with U.S. FDA (Dec.’96). In 1998, Dr. Molnar set up the manufacturing of fetal precursor cell xeno-transplants, based on his U.S. patent application “Cell and Tissue Xenotransplants” and related know-how. In February 1999, four IND applications for the treatment of diabetic complications by cell transplantation of animal fetal origin, written by Dr. Molnar, were filed with U.S. FDA thereby establishing GMP rules for fetal precursor cell transplantation.

Dr. Molnar is Director (since 1989) of Bio-Cellular Research Organization of Stem Cell Transplantation Limited, the first and only manufacturer of fetal precursor cell xeno-transplants since 1998. He is very likely the world’s foremost expert on fetal precursor cell transplantation, the key component of successful treatment of incurable and no longer treatable diseases.

In 2012 Dr. Molnar published in U.S. his book for general public ‘Treatment of Incurable and Untreatable Diseases’.

In 2014 on was published his book ‘Fetal Precursor Cell Transplantation, BCRO Fetal Precursor Cell Transplantation’.

Seven years ago Dr. Molnar was declared the ‘father of cell transplantation’ in Russia. More recently he became ‘father of fetal precursor cell transplantation’ in Asia, the first lecturer on this subject in the majority of Asian countries.
Study of his book teaches the medical professional all that is necessary to know for an effective clinical practice in cell transplantation.


  1. Molnar, E. Michael. Treatment of Incurable and Untreatable Diseases. Washington, D.C.: Medical and Engineering Publishers Inc., 2013.
  2. Stem Cell Transplantation, a Textbook of Stem Cell Xeno-Transplantation. Washington, D.C.: Medical and Engineering Publishers Inc., 2006.
  3. Forever Young. West Hartford, Conn.: The Witkower Press Inc., 1985.
  4. Forever Young 2. U.K.: Lightning Press, 2003.
  5. “Cell Transplantation and Myocardial Regeneration.” Handbook of Cell Transplantation in Cardiovascular Medicine. Kipshidze, N. & Serruys, P.W. UK: Dunitz, 2003.
  6. “Impedance of the Middle Ear”. Master of Science thesis, Graduate College, University of Illinois at the Medical Center, Chicago, Illinois.
  7. Cell Transplantation for Myocardial Regeneration. Turkey: European Journal of General Medicine, April 2005.
  8. Report on Medical Research Project in Transplantation of Human Fetal Tissues in Russia. Medorganica (Germany), 17, 57-61, 1993.
  9. Anikin, Molnar, et al. Opioid peptides improve human fetal tissue survival after cryopreservation in culture. Bull. Exp. Biol & Med., 117, 4, pp 408-411, 1994.
  10. Bozhedomov, Molnar, et al. Possibilities of clinical transplantation of testis as organ and tissue, Bull. Exp. Biol & Med., 117, 4, pp 400-404, 1994.
  11. Droppa and Molnar, E.M. ENT Syndromes in Geriatrics. Czechoslovak Otolaryngology, 1969.
  12. Kulakov, Molnar, et al. Effects of transplantation of human fetal tissues on CNS function in patients with post-castration syndrome. Bull. Exp. Biol& Med., 117, 4, pp 382-385, 1994.
  13. Kulakov, Molnar, et al. Mammary glands in patients with post-castration syndrome treated by transplantation of human fetal tissues. Bull. Exp. Biol& Med., 117, 4, pp 386-388, 1994.
  14. Kulakov, Molnar, et al. State of automatic regulation in patients with post-castration syndrome after transplantation of human fetal tissues. Bull. Exp. Biol & Med., 117, 4, pp 405-407, 1994.
  15. Kulakov, Molnar, et al. Imunocytotherapy: New trend in fetal tissue transplantation. Bull. Exp. Biol & Med., 117, 4, pp 412-415, 1994.
  16. Kurnosova, Molnar, et al. Modern concepts of structural bases for reparative regeneration of mammal and human testis. Bull. Exp. Biol & Med., 117, 4, pp 396-399, 1994.
  17. Malaitsev, Molnar, et al. Transplantation of human fetal tissues as a promising method in the treatment of diabetes mellitus. Bull. Exp. Biol &Med., 117, 4, pp. 350 – 355, 1994.
  18. Molnar, E.M. and Torok, N.Effect of the Ocular Fixation on the Caloric Nystagmus. ORL 36:75-84, 1974.
  19. Panchenko, Molnar, et al. A comparative study of institutionalized children with Down Syndrome. Medorganica, 17, 124-5, 1993.
  20. Panchenko, Molnar, et al. Debre-De Toni-Fanconi-Syndrome: Treatment of childhood kidney disease by transplantation of human fetal tissues. Medorganica, 18, 16-19, 1994.
  21. Panchenko, Molnar, et al. Experience of use of transplantations of human fetal tissues in children with Down Syndrome. Bull. Exp. Biol & Med., 117, 4, pp 373-374, 1994.
  22. Panchenko, Molnar, et al. Effectiveness of transplantation of human fetal tissues in treatment of children with de Toni-Debre-Fanconi’s syndrome. Bull. Exp. Biol & Med., 117, 4, pp 392-395, 1994.
  23. Saveliev, Molnar, et al. Human fetal and xenogeneic neural tissue transplantations in Parkinsonism. Bull. Exp. Biol & Med., 117, 4, pp 369-372, 1994.
  24. Skaletskii, Molnar, et al. Transplantation of cultured fetal pancreatic islet cells in the treatment of insulin dependent diabetes mellitus. Bull. Exp. Biol & Med.,117, 4, pp. 256 – 363, 1994.
  25. Smirnov, Molnar, et al. Treatment of deep burns with human fetal tissues. Bull. Exp. Biol & Med., 117, 4, pp 405-407, 1994.
  26. Sukikh, Molnar, et al. Transplantation of human fetal tissues in hematology. Bull. Exp. Biol & Med., 117, 4, pp 375-377, 1994.
  27. Yegorov, Molnar, et al. Experience in treatment of habitual abortion of adrenal etiology by transplantation of adrenal tissue culture from newborn suckling pigs. Bull. Exp. Biol & Med., 117, 4, pp 389-391, 1994.